logoTry Persana

Felix Biotechnology - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Felix Biotechnology including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Felix Biotechnology company logo

Felix Biotechnology is focused on discovering, developing and deploying customizable antimicrobials targeting urgent microbial threats.

HeadquartersSan Francisco, CA, United States
Team size1-50
Founded2019

What is Felix Biotechnology? - Company Overview & Details

Felix Biotechnology is Felix Biotechnology is focused on discovering, developing and deploying customizable antimicrobials targeting urgent microbial threats. Founded in 2019, the company is headquartered in San Francisco, CA, United States.

Who are the Key Executives at Felix Biotechnology? - Leadership Team

Felix Biotechnology is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Felix Biotechnology

CEO

Chief Technology Officer (CTO) of Felix Biotechnology

CTO

Felix Biotechnology Company Details & Key Information

Where is Felix Biotechnology located?

Felix Biotechnology is headquartered in San Francisco, CA, United States.

How many employees does Felix Biotechnology have?

Felix Biotechnology has 1-50 employees.

When was Felix Biotechnology founded?

Felix Biotechnology was founded in 2019.

Felix Biotechnology Official Website

How much funding has Felix Biotechnology raised?

Felix Biotechnology has raised undisclosed amount. The most recent funding was completed on 2022-07-14.

Funding Overview

Felix Biotechnology received a total of $314,411 in a competitive grant from the National Institutes of Health to develop a microfluidics platform for phage-engineering.

N/A
Total Funding Raised
0
Funding Rounds
2022-07-14
Latest Round

Felix Biotechnology Funding History

NIH Grant
2022-07-14
$314,411
NSF Grant
2021-09-01
$256,000

Who are the key investors in Felix Biotechnology?

Felix Biotechnology is backed by 3 key investors including Y Combinator, Illumina Accelerator, Point72 Ventures. These investors focus on sectors.

Felix Biotechnology Investor Overview

3
Key Investors
1
Focus Areas
0
Notable Investments

Complete List of Felix Biotechnology Investors

Y Combinator

A startup accelerator that invests early in companies.

Illumina Accelerator

A program focused on advancing the next generation of genomics technologies.

Point72 Ventures

Investment firm focusing on advanced technology and innovation.

What sectors do Felix Biotechnology investors focus on?

The investors backing Felix Biotechnology primarily focus on sectors.

Featured Investor: Y Combinator

Y Combinator

A startup accelerator that invests early in companies.

What are Felix Biotechnology's future plans?

Felix Biotechnology Strategic Outlook

Strategic Focus
In Development
1
Key Challenges
1
Growth Opportunities

What challenges does Felix Biotechnology face?

Felix Biotechnology has identified 1 key challenges that need to be addressed for continued growth and success.

Key Challenges for Felix Biotechnology

1

Securing further funding for ongoing research

What opportunities does Felix Biotechnology have?

Felix Biotechnology has identified 1 key opportunities for growth and market expansion.

Growth Opportunities for Felix Biotechnology

1

Expanding into phage-based therapies for both human and animal health

Felix Biotechnology Strategic Position Summary

Key Focus Areas

Felix Biotechnology is addressing 1 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 1 key opportunities for expansion and growth.

What are the latest news about Felix Biotechnology?

Felix Biotechnology has 2 recent news updates covering key business developments and market activities.

Felix Biotechnology News Overview

2
Recent Articles
Active
Media Coverage
2023-04-19
Latest Update

What is Felix Biotechnology in the news for?

Felix Biotechnology is currently featured in news for Felixbt invests into assets: prescription fulfillment warehouses in the amount of $13.3M. and other significant business developments.

Recent News Articles About Felix Biotechnology

Article 1
2023-04-19

Felixbt invests into assets: prescription fulfillment warehouses in the amount of $13.3M.

Felix has begun moving into more complex categories of care, including weight loss, coaching, and therapy.

betakit.com
Read News
Article 2
2022-07-14

National Institutes of Health invested into Felixbt $314K on Jul 14th '22.

Felix Biotechnology awarded competitive grant from the National Institutes of Health to power phage engineering platform.

prnewswire.com
Read News

Felix Biotechnology FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Felix Biotechnology including information about founders, CEO, funding history, investors, headquarters location, and company details. 13 frequently asked questions covering key information about the company.

Felix Biotechnology Questions & Answers - Company Information

Q1

What is Felix Biotechnology?

Felix Biotechnology is focused on discovering, developing and deploying customizable antimicrobials targeting urgent microbial threats.

Q2

Who are the investors in Felix Biotechnology?

Felix Biotechnology's key investors include Y Combinator, Illumina Accelerator, Point72 Ventures.

Q3

Where is Felix Biotechnology headquartered?

Felix Biotechnology is headquartered in San Francisco, CA, United States.

Q4

When was Felix Biotechnology founded?

Felix Biotechnology was founded in 2019.

Q5

How many employees does Felix Biotechnology have?

Felix Biotechnology has 1-50 employees.

Q6

What is Felix Biotechnology's official website?

You can visit Felix Biotechnology's official website at http://www.felixbt.com.

Q7

What was Felix Biotechnology's latest funding round?

Felix Biotechnology's latest funding round was a NIH Grant round of $$314,411 completed on 2022-07-14.

Q8

What does the company do?

Felix Biotechnology is focused on discovering, developing and deploying customizable antimicrobials targeting urgent microbial threats.

Q9

Latest funding date?

2022-07-14

Q10

Who are the investors?

Y Combinator Illumina Accelerator Point72 Ventures

Q11

What are the challenges?

Securing further funding for ongoing research

Q12

What are the opportunities?

Expanding into phage-based therapies for both human and animal health

Q13

Latest news?

Felix has begun moving into more complex categories of care, including weight loss, coaching, and therapy. Felix Biotechnology awarded competitive grant from the National Institutes of Health to power phage engineering platform.

More Information About Felix Biotechnology

For additional details about Felix Biotechnology, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.